Stiripentol Dosing Guide for Children: Initiation, Titration, and Managing Drug Interactions

Whether long-term administration of stiripentol is required depends on the control of the condition and the physician’s evaluation. This medication is mainly used for refractory epilepsy such as Dravet syndrome, and usually requires long‑term use to maintain efficacy, but it is not absolutely contraindicated to discontinue. The specific regimen must be adjusted strictly in accordance with medical advice; patients must not stop or reduce the dose on their own.

Principles of stiripentol administration

Individualized treatment

The duration and dosage of treatment are determined comprehensively based on the patient’s seizure frequency, drug response, and side effects. Some patients may require lifelong medication; if the condition is stable and the risk is considered manageable by a physician, gradual dose reduction may also be possible.

Avoid abrupt discontinuation

Sudden withdrawal of antiepileptic drugs may lead to worsening seizures or withdrawal reactions. Therefore, any medication adjustment must be carried out gradually under medical supervision.

Situations requiring discontinuation or dose adjustment

Severe side effects: such as liver dysfunction, allergic reactions, etc. Immediate medical attention and adjustment of the treatment plan are required.

Good seizure control: after physician evaluation, an attempt may be made to gradually reduce the dose while monitoring for seizure recurrence.

Adjustment of combination therapy: if other antiepileptic drugs are co‑administered, the regimen should be coordinated according to the overall treatment plan.

Precautions

Strictly follow medical advice: stiripentol is a prescription drug. Regular follow‑up visits are required during treatment to monitor blood drug concentration, liver and renal function, and other indicators.

Patient and family education: understand the drug’s effects, side effects, and emergency management measures. Contact a physician promptly if any abnormalities occur.

In summary, the treatment regimen of stiripentol requires dynamic adjustment. Patients should maintain close communication with neurologists or pediatricians to ensure the safety and efficacy of treatment through standardized therapy and regular follow‑up.